Figure 3

The pairwise comparisons of 5-year OS rates (A) and recurrence-free survival (B) in patients with pN2a1, pN2a2 and pN2b.

The pairwise comparisons of 5-year OS rates (A) and recurrence-free survival (B) in patients with pN2a1, pN2a2 and pN2b.